We invite you to watch this webinar to learn about recent advances in GPU technology for the pharmaceutical and biopharma industry. We'll show a three- to tenfold speed-up in turnaround time and how streamlining the workflow allows for creating Design of Experiments (DOE).ent pathway for using CM&S in submissions.

What if you could almost instantaneously predict the likely evolution of the bioreactor exposed to adverse internal or external events so that you can take corrective measures?

Existing diagnostic and treatment methods for pulmonary diseases face challenges. Artificial Intelligence (AI) algorithms present novel opportunities for enhancing diagnostic accuracy and personalizing treatment plans. Learn how the CFD approach can improve diagnostic accuracy in this upcoming webinar.

Learn what computer modeling and simulation means for the healthcare industry. We’ll calculate the benefits and expected return on investment in this webinar.

Recent advances in Ansys Fluent free surface (VOF) capabilities enable users to run more realistic and complex mixing tank simulations. In this webinar, we discuss the best practices to run these simulations.

In this webinar, we present different case studies that explain the different modeling options available in Ansys Fluent for simulation of different physical processes that occur in a mixing tank.

This webinar spotlights how Ansys CFD simulations help design chromatography columns and includes a quick tutorial that demonstrates the entire process.

Ansys Consulting helped this pharmaceutical company to develop accurate scale-up conditions by performing steady-state and transient simulations at each scale.

Antleron designed custom bioreactors that place living cells in the best environment for growth and modification.

The global healthcare industry emits more greenhouse gases than all but four countries. That means if the healthcare industry were a country, it would be the fifth largest global emitter of CO2. In recent years, the United States and United Kingdom healthcare sectors have accounted for around one-tenth of each country’s annual greenhouse gas emissions.

Pharmaceutical production begins with upstream processing. At this stage, the manufacturer gathers the required raw ingredients, including active pharmaceutical ingredients (APIs), water, solvents, and other chemicals. These components must be blended in specific proportions under tightly controlled conditions to ensure the quality and consistency of the final product. But this process is far from simple. Mixtures and environments must be exact, or expensive resources go to waste and companies lose their competitive advantage.

The downstream chemical pharmaceutical and biopharmaceutical production processes consist of several essential steps in which product mixtures are refined, separated, and turned into finished tablets, capsules, and vaccines